What Does Ozempic Do to Your Body? The Science Behind Semaglutide’s Effects

When researchers began publishing data on semaglutide — the active ingredient in Ozempic and Wegovy — the medical community took notice quickly. Weight loss of 15 to 20 percent of body mass in clinical trials was unprecedented for a non-surgical intervention. But what exactly is happening inside your body when you inject this drug weekly? The answer is more complex, and in some ways more interesting, than the headlines suggest.

How Semaglutide Changes Your Metabolism From the Inside Out

Semaglutide is a glucagon-like peptide-1 receptor agonist, or GLP-1 RA. GLP-1 is a hormone your gut naturally releases after eating. It signals your pancreas to produce insulin, tells your liver to slow down glucose output, and — critically — communicates with appetite-regulating centers in the brain, particularly the hypothalamus. Semaglutide mimics this hormone but with a half-life engineered to last roughly a week rather than minutes.

The result is a sustained reduction in appetite that most users describe not as willpower, but as a fundamental shift in how food is perceived. Cravings diminish. Portion sizes shrink naturally. The concept sometimes called “food noise” — the constant mental preoccupation with eating — gets quieter. This central effect on appetite is arguably the drug’s most powerful mechanism, and it explains why weight loss on semaglutide feels categorically different from caloric restriction alone.

Beyond appetite, semaglutide slows gastric emptying — the rate at which food moves from your stomach into the small intestine. This contributes to prolonged feelings of fullness after meals and blunts post-meal blood sugar spikes. For men with insulin resistance or type 2 diabetes, this mechanism is particularly meaningful. Blood glucose becomes more stable, insulin sensitivity improves, and the metabolic chaos that drives fat accumulation begins to resolve.

The cardiovascular data is compelling as well. The SELECT trial — a landmark study involving over 17,000 participants — found that semaglutide reduced major adverse cardiovascular events by 20 percent in overweight and obese adults without diabetes. These effects appear to go beyond weight loss alone, suggesting direct cardioprotective mechanisms that researchers are still working to fully characterize.

The Effects That Don’t Make the Brochure

No drug reshapes your physiology this dramatically without downstream consequences worth understanding. The rapid caloric deficit semaglutide produces is real, and the body responds to it in ways that mirror what happens during any aggressive weight loss phase — just faster and more pronounced for many users.

One of the more underappreciated effects involves thyroid hormone dynamics. A 2026 case report published in Clinical Medicine Insights: Endocrinology and Diabetes described a 54-year-old woman who lost 22 kilograms over four months on semaglutide and subsequently developed fatigue, lethargy, and cold intolerance. Her thyroid labs showed low free T3 with normal TSH — the classic pattern of euthyroid sick syndrome, or ESS. Importantly, her thyroid gland itself was functioning normally. The abnormal labs reflected her body’s adaptive response to the catabolic stress of rapid weight loss: a protective downregulation of metabolism. Her symptoms resolved as her weight stabilized and her protein and caloric intake improved. No thyroid medication was needed. This case is a useful reminder that labs during aggressive weight loss phases need clinical context, not reflexive treatment.

Muscle loss is another legitimate concern. When you lose weight rapidly through any mechanism — caloric restriction, GLP-1 medications, or both — the body doesn’t selectively burn fat. Lean mass is at risk too, and emerging data suggests the muscle loss percentage on semaglutide may be proportionally higher than what’s seen in slower, more traditional weight loss approaches. This is not an argument against the medication, but it is a strong argument for resistance training and adequate protein intake throughout treatment. Men on semaglutide who lift weights and prioritize 1.6 to 2.2 grams of protein per kilogram of body weight consistently fare better in terms of body composition outcomes.

Gastrointestinal side effects — nausea, vomiting, constipation, and diarrhea — are the most commonly reported adverse effects and the primary reason people discontinue treatment. These symptoms are dose-dependent and typically worst during the titration phase. Slower titration, smaller meals, and avoiding high-fat foods during ramp-up reduces their severity for most users. What’s worth noting from a clinical safety standpoint is that severe vomiting without adequate fluid replacement can cause meaningful dehydration and hemoconcentration — a thickening of the blood that has been proposed as one mechanism in rare thromboembolic complications.

A 2026 case report in Cureus documented a 16-year-old male who developed deep venous thrombosis in the left leg within two weeks of starting oral semaglutide without medical supervision. The authors noted hemoconcentration from GI side effects, prolonged sedentary behavior, and potential GLP-1 effects on coagulation and endothelial function as possible contributing factors. DVT in association with semaglutide remains rare, but this case underscores a critical point: these are powerful medications that deserve clinical oversight, not self-prescription, especially in younger individuals or those with additional risk factors.

What This Means for You

Ozempic does something genuinely remarkable — it interrupts the neurobiological drivers of overeating and improves metabolic health markers that were once considered difficult to move without surgery. For men struggling with obesity-related metabolic disease, the risk-benefit calculation often favors its use when properly supervised.

But the drug doesn’t replace the fundamentals. Protein targets, resistance training, hydration, and adequate sleep aren’t optional add-ons while on semaglutide — they’re what determine whether you lose fat and preserve muscle or simply lose weight. And monitoring matters. Thyroid symptoms during rapid weight loss, unusual leg pain or swelling, or signs of dehydration from GI side effects should prompt a conversation with your physician, not a Google search.

The science around semaglutide is evolving fast. What’s already clear is that it works through biology, not magic — and understanding that biology gives you a meaningful advantage in using it well.